Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Balk

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Cardiovascular Electrophysiology|February 22, 2011
Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathyKadir Caliskan, Tamas Szili-Torok, Dominic A M J Theuns, et al.
Transplantation Proceedings|November 15, 2002
Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantationN M van Besouw, A H M M Balk, M van Vliet, et al.
Stem Cells and Development|September 6, 2007
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacitiesM J Hoogduijn, M J Crop, A M A Peeters, et al.
Transplant Immunology|May 3, 2003
Recipient gene polymorphisms in the Th-1 cytokines IL-2 and IFN-gamma in relation to acute rejection and graft vascular disease after clinical heart transplantationC T J Holweg, A M A Peeters, A H M M Balk, et al.
Transplantation|June 15, 2007
Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patientsI Esmé Dijke, Jurjen H L Velthuis, Kadir Caliskan, et al.
Transplantation|May 1, 2002
Effect of HLA-DR matching on acute rejection after clinical heart transplantation might be influenced by an IL-2 gene polymorphismCecile T J Holweg, Annemiek M A Peeters, Aggie H M M Balk, et al.
Transplantation|November 14, 2008
Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycinMartin J Hoogduijn, Meindert J Crop, Sander S Korevaar, et al.
The American Journal of Cardiology|April 13, 2002
Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imagingAbdou Elhendy, Ron T van Domburg, Pascal Vantrimpont, et al.
Journal of Cardiac Failure|December 11, 2007
Predictors of cardiac events after cardiac resynchronization therapy with tissue Doppler-derived parametersOsama I I Soliman, Dominic A M J Theuns, Folkert J Ten Cate, et al.
European Heart Journal|September 27, 2005
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart FailureMattie J Lenzen, Eric Boersma, Wilma J M Scholte Op Reimer, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Cardiovascular Electrophysiology|February 22, 2011
Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathyKadir Caliskan, Tamas Szili-Torok, Dominic A M J Theuns, et al.
Transplantation Proceedings|November 15, 2002
Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantationN M van Besouw, A H M M Balk, M van Vliet, et al.
Stem Cells and Development|September 6, 2007
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacitiesM J Hoogduijn, M J Crop, A M A Peeters, et al.
Transplant Immunology|May 3, 2003
Recipient gene polymorphisms in the Th-1 cytokines IL-2 and IFN-gamma in relation to acute rejection and graft vascular disease after clinical heart transplantationC T J Holweg, A M A Peeters, A H M M Balk, et al.
Transplantation|June 15, 2007
Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patientsI Esmé Dijke, Jurjen H L Velthuis, Kadir Caliskan, et al.
Transplantation|May 1, 2002
Effect of HLA-DR matching on acute rejection after clinical heart transplantation might be influenced by an IL-2 gene polymorphismCecile T J Holweg, Annemiek M A Peeters, Aggie H M M Balk, et al.
Transplantation|November 14, 2008
Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycinMartin J Hoogduijn, Meindert J Crop, Sander S Korevaar, et al.
The American Journal of Cardiology|April 13, 2002
Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imagingAbdou Elhendy, Ron T van Domburg, Pascal Vantrimpont, et al.
Journal of Cardiac Failure|December 11, 2007
Predictors of cardiac events after cardiac resynchronization therapy with tissue Doppler-derived parametersOsama I I Soliman, Dominic A M J Theuns, Folkert J Ten Cate, et al.
European Heart Journal|September 27, 2005
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart FailureMattie J Lenzen, Eric Boersma, Wilma J M Scholte Op Reimer, et al.
Pageof 7